- Original article
- Open access
- Published:
Molecular characterization of plasma virome of hepatocellular carcinoma (HCC) patients
AMB Express volume 14, Article number: 46 (2024)
Abstract
Hepatocellular carcinoma (HCC) stands as the most common cancer type, arising from various causes, and responsible for a substantial number of cancer-related fatalities. Recent advancements in viral metagenomics have empowered scientists to delve into the intricate diversity of the virosphere, viral evolution, interactions between viruses and their hosts, and the identification of viral causes behind disease outbreaks, the development of specific symptoms, and their potential role in altering the host’s physiology. The present study had the objective of “Molecular Characterization of HBV, HCV, anelloviruses, CMV, SENV-D, SENV-H, HEV, and HPV viruses among individuals suffering from HCC.” A total of 381 HCC patients contributed 10 cc of blood each for this study. The research encompassed the assessment of tumor markers, followed by molecular characterization of HBV, HCV, Anelloviruses (TTV, TTMV, and TTMDV), SENV-H and SENV-D viruses, HEV, CMV, and HPV, as well as histopathological examinations. The outcomes of this study revealed that majority of the HCC patients 72.4% (276/381) were male as compared to females. HCV infection, at 76.4% (291 out of 381), exhibited a significant association (p < 0.05) with HCC. Most patients displayed singular lesions in the liver, with Child Pugh Score Type B being the predominant finding in 45.2% of cases. Plasma virome analysis indicated the prevalence of TTMDV (75%), followed by TTMV (70%) and TTV (42.1%) among anelloviruses in HCC patients. Similarly, SENV-H (52%) was followed by SENV-D (20%), with co-infections at 15%. The presence of CMV and HEV among the HCC patients was recorded 5% each however 3.5% of the patients showed the presence of HPV. In conclusion, this study underscores that HCC patients serve as reservoirs for various pathogenic and non-pathogenic viruses, potentially contributing to the development, progression, and severity of the disease.
Introduction
Hepatocellular carcinoma (HCC) stands as a leading cause of tumor-related fatalities, accounting for 745,000 annual deaths among males. Additionally, there are 800,000 new cases reported each year, with a projected increase to one million cases annually after 2025. HCC is currently ranked as the sixth most prevalent cancer type (Lovet et al. 2021). Most of the live cancer (70-90%) are HCC (El-Serag 2012) whose rate of mortality is increasing among North American and European countries. Many factors, both genetic and environmental, such as hereditary hemochromatosis, obesity, diabetes, aflatoxin exposure, and excessive alcohol consumption, significantly contribute to the development of hepatocellular carcinoma (HCC) (Gomaa et al. 2008). Furthermore, a significant portion of cases of hepatocellular carcinoma (HCC), estimated to be between 60 and 70%, has been attributed to chronic infections of the hepatitis C virus (HCV) or hepatitis B virus (HBV) (Ferlay et al. 2015), with a global incidence rate of 16 cases per 100,000 individuals. However, our understanding of the relationship between HCC and the hepatitis D virus (HDV) remains limited (Romeo et al. 2018). Additionally, majority of the HCC (60-70%) have been linked with infection of chronic hepatitis C virus (HCV) or hepatitis B virus (HBV) with an incidence rate of 16/100,000 cases worldwide, however less is known about the association with hepatitis D virus (HDV) (El-Serag 2012).
The microbiome refers to the combined genetic material of the diverse microbial populations that inhabit the human body, including bacteria (bacteriome), viruses (virome), archaea (archaeome), and protozoa (parasitome) (Berg et al. 2020). These microorganisms exist in symbiosis with the human host, residing in different locations within the body such as the gastrointestinal system, skin, respiratory tract, genital organs, and oral cavity (Lloyd-Price et al. 2016). Because of their significant involvement in human physiology, metabolism, nutrition and immune system this organ exert a significant influence on human health (Ley et al. 2008). In recent progress within the realm of viral metagenomics, a notable breakthrough occurred in discerning the evolution of viruses and exploring the diversity present within the virosphere (Chow and Suttle 2015; Paez-Espino et al. 2016; Zhang et al. 2018; Shi et al. 2018). Furthermore, characterization of viruses that causes outbreaks of diseases or specific symptoms (Delwart 2012; Zhou et al. 2020; Grard et al. 2012; Edridge et al. 2019; Ma et al. 2021; Wang et al. 2019), virus-host interaction and their significant role in disease and physiology of the host (Hannigan et al. 2018; Norman et al. 2015; Legoff et al. 2017; Lang et al. 2020; Zhao et al. 2017; Li et al. 2019) are also explored significantly. Additionally, in human context, the impartial viral metagenomics study significantly improves the identification and characterization of the viral sequences present in both diseased and healthy individuals which is used in clinical settings and increasingly accepted (Wilson et al. 2019; Zanella et al. 2021; Moustafa et al. 2017).
The main focus of prior research studies on human virome targeted skin, respiratory tract and gut viruses(Minot et al. 2013; Nayfach et al. 2021; Handley 2016; Dodi et al. 2021; Choi et al. 2021; Oh et al. 2016), however, the plasma/blood virome are also equally important as it comprises on both pathogenic and non-pathogenic or commensal viruses (Moustafa et al. 2017). Numerous viral infections can disrupt or alter the composition of the plasma virome. For instance, contracting HIV-1 may result in an elevated viral load of HERV (human endogenous retrovirus) and anellovirus (Li et al. 2012, 2013). The changes in the virome, specific to each infection, appear to be connected to a weakened immune system, which contributes to the advancement of the disease. This makes it challenging for researchers to determine whether the viruses already present in one’s system affect their overall health and play a role in their immune response (Liu et al. 2021). On the other hand, the characterization of blood and plasma virome analysis is equally important. This characterization plays a crucial role in ensuring the safety of transfusions and in monitoring for the presence of pathogenic viruses that can potentially spread during organ transplants or blood transfusions, leading to severe complications in different individuals (Zanella et al. 2020, 2021). The advancement in the field of metagenomics revealed the novel virus diversity involved in human health with a new ecological perspective (French and Holmes 2020; Hsu et al. 2021; Koonin et al. 2021; Liang and Bushman 2021). The most frequently observed viruses present in human plasma belong to the anelloviridae family, and they are often detected in conjunction with other non-pathogenic viruses (such as TTMV and TTV) as well as pathogenic viruses (including HSV, HPV, HIV, and HEV). These co-infections could potentially impact the severity of Hepatocellular Carcinoma (HCC). In Pakistan, there has been a recent increase in HCC cases throughout the country, prompting the need to investigate the common plasma virome in HCC patients. Therefore, the current study was conducted with the objective of molecularly characterizing the plasma virome in patients with HCC associated with HBV-HCV and those without this association, across different stages of the disease.
Methodology
Study design and ethical approval
This descriptive study was conducted at Molecular Virology Laboratory, Department of Biosciences, COMSATS University, Islamabad in collaboration with DINAR (D.I Khan Nuclear Medicine and Radiotherapy) Hospital, Mufti Mehmood Teaching Hospital, and MARDAN Medical Complex from September 2018 to October 2019. The current study was ethically approved from institutional ethical committee of COMSATS University, Islamabad, Pakistan under Ethical Approval No. CUI-Reg/Notif. 2255/20/2691.
Sample collection and processing
The current study used Open Epi calculator for sample size calculation keeping the prevalence rate of 10.7% of all types of cancer (95% confidence interval) for statistical assumptions of HCC as described earlier (Shehzad et al. 2019). As per calculation the required sample size was 145 patients. However, 381 patients were included in the study by using consecutive sampling method, irrespective of the gender and age of the patients. Patients with undergoing treatment or visiting for follow up were excluded from this study.
Demographic characteristics and serological assessment
A detailed clinical history including age and gender of entire HCC patients were obtained through a comprehensive questionnaire. The status of patient’s performance were graded from 0 to 5 as per the criteria mentioned by WHO (Aljumah et al. 2016). Initial diagnosis of HCC was confirmed through α fetoprotein (AFP) > 400 followed by computed tomography (CT) scan of chest and liver. Milan’s criteria and BCLC was adopted for the diagnosis of various HCC stages (Llovet et al. 2008) including performance status of patients using ECOG criteria, size and spread of tumor (Oken et al. 1982). MELD criteria (Kamath and Kim 2007) and Child Pugh Score (Pugh et al. 1973; Child and Turcotte 1964) was used for the assessment of underlying chronic liver disease. Patients were divided in three different groups Child Class A (Child Pugh Score = 5–6), Class B (Child Pugh Score = 7–9) and Class C (Child Pugh score = 10–15) (Hafeez et al. 2020). Blood (05 ml) was taken under aseptic conditions in a clot activator gel tube and serum was separated by centrifugation at 5000 rpm for 03 min and was stored in aliquots at -20 °C.
Nucleic acid extraction and cDNA Preparation
A total of 200 µl of Serum sample was used for nucleic acid (DNA/RNA) extraction by using Tianlong™ viral nucleic acid extraction kit (Suzhou Tianlong Bio-technology Co., LTD) in accordance with the manufacturer’s instructions. cDNA was prepared through RT-PCR followed by qualitative confirmation of entire viruses.
Molecular characterization of HCV/HBV and prevalent viral genome
The quantitative analysis of HBV/HCV and other prevalent viruses (Anelloviruses, SEN virus, Herpes viruses, HPV) was performed. Primer sets were utilized to amplify the specific region confirming viral presence or absence (Table 1.). Initially a total of 25 µl of PCR mixture was prepared by mixing 5 µl DNA with 1 µl + 1 µl forward and reverse primer each, 5 µl commercially prepared master mix and 13 µl sterilized PCR water. For the nested PCR (SENV), in first round of PCR universal set of primers was used (S1, S2, S3 Tables). In second-round of PCR, 2 µl PCR product from round-one was used as template making total volume of 20 µl and specific primers were used which amplify specific region of viral genome. Initial denaturation was done at 95˚C for 5 min, following denaturation at 95˚C for 30 s, primer annealing at various temperature (Table 1) for 30 s, extension 72˚C for 45 Sect. (35 cycles), and final extension at 72˚C for 10 min.
Statistical analysis
The entire collected data was fed into SPSS (ver. 16.00) and chi-square test was applied by keeping 95% CI and P < 0.05 considered as statistically significant.
Results
Demographic assessment of patients
Demographic and clinical observation showed that majority of HCC patients were males 72.4% (276/381) as compare to female 27.6% (105/381) where the mean age of the patients was 60.4 ± 8.67 years. Among the pathogenic hepatotropic viruses the prevalence of HCV 76.4% (291/381) was higher as compare to HBV 11.5% (44/381) in HCC patients. Majority of the patients restricted their physical activity, able to do sedentary work in their performance status 79% (301/381). Higher number of HCC patients was of Type B 45.2% (172/381) followed by Type C 25.2% (96/381) on the basis of Child Pugh score. Larger number of HCC patients 50.7% (193/381) presented BCLC stage B (intermediate), C or D (advanced) stage of HCC. For entire data see Table 1.
Serological analysis of hepatocellular carcinoma patients
Among the entire studied population, a total of 28.9% (110/381) has elevated level of AFP (400–1000) while 40.2% (153/381) of the patients presented 02 or more liver lesions where vascular lesion was observed in 31.2% (119/381) HCC patients as shown in the Table 2.
Serological and molecular detection of HBV/HCV in HCC patients
Serological assessment showed that 80% (305/381) were positive for anti-HCV antibodies among which molecular confirmation observed 76.4% (291/381) subject’s positive for active HCV infection (Fig. 1). Serological analysis for HBV showed that 20% (78/381) of the samples were positive for anti-HBsAg which upon molecular confirmation 11.5% (44/381) were with active HBV infection as shown in the Fig. 1.
Detection of SEN virus
Among HCC infected individuals, 52% patients had a strong active infection of SENV-H while SENV-D was identified in 20% patients and 15% patients had co-infection of both SENV-D and H (Fig. 2). While in healthy control, the occurrence rate of SENV-D and SENV-H among healthy blood donors was 36% and 75% respectively, and 30% individual had co-infection of both SENV-D and SENV-H. The frequency of SEN virus types in healthy blood donors is given below Fig. 2.
Detection of anelloviruses
Among Anelloviruses, TTMDV was detected in 75% followed by TTV was found in 42.1%.
The co-infection of TTMV was found in 70% of the samples whereas (Fig. 3). Healthy control group, showed the presence of only TTV (2.3%).
Detection of HEV, HSV and anelloviruses
Molecular characterization of Herpes viruses (HSV, CMV, VZV, EBV) among HCC patients showed that out of total samples, HEV and CMV were found in 5% of HCC patients indicating presence of viral infection among them. Other viruses including HPV were of 3.5% in prevalence in HCC patients (Fig. 3).
Discussion
Globally, Hepatocellular Carcinoma (HCC) is the 3rd most frequent cause of cancer-associated mortality being the 7th leading cause of cancer in female and 5th in male and remains dominant in south-east and east Asia (Torre et al. 2015) because of high prevalence of HBV and HCV infection. A total of 381 HCC patients were studied in the current study where male (72.4%) dominating over females as described by other studies earlier (Bray et al. 2018). It could be proposed that androgens have a tumorigenic impact; nevertheless, the precise mechanism remains unexplored (Abbasi et al. 2010). Globally, according to a comprehensive study, both HBV and HCV were the topmost causes of HCC (de Martel et al. 2015). Data reported from Pakistan showed that since 1987 till 2010 approximately 50–60% followed by 20–30% of cases of HCC were infected by HCV and HBV respectively (de Martel et al. 2015). Similarly, in the current study on HCC patients we noted that HCV was most prevalently observed (76.4%) followed by HBV infected (11.5%) as reported similarly from Pakistan (Shehzad et al. 2019). In most of the cases the HCC is associated with the infective agents including HBV and HCV and considered as preventable where in USA it’s incidence become almost tripled between 1975 and 2011 because of high intravenous drugs abusers and increased prevalence of HCV during 1960s and 1970s (Torre et al. 2015). Concurrently, some studies in high risk area of other countries like Japan, China and Taiwan reported the decreasing incidence of HCC because of applying sufficient measures and vaccination against HCV and HBV (Torre et al. 2015). Besides, coinfection with HCV, HBV and HIV, diabetes mellitus, obesity and use of alcohol and lack of mass level awareness are important risk factors for the development of HCC (Mittal et al. 2016; Umer and Iqbal 2016). These studies indicate that by applying appropriate preventive measures like Proper sterilization and avoiding reuse of medical devices for the control of viral agents, mass level awareness, development of competent surveillance measures for early stage diagnosis of HCC and anti-hepatotropic vaccinations, HCC might be controlled/prevented (Kaya et al. 2022; Umer and Iqbal 2016).
The current study also observed that 43% of our populations had single solitary lesion followed by 40.2% with 2–3 solitary lesion as somewhere already reported from the adjacent area of Pakistan (Shehzad et al. 2019). Similarly, in most of the patients (35.9%) the tumor size was 3–5 cm followed by 5–10 cm which is comparable with different previous studies (Curley et al. 2015; Shehzad et al. 2019). The possible reason for higher detection of more than one lesion might be the absence of fully trained sonologist (Curley et al. 2015) as well as the absence of an acute onset and silent progression of the disease till the development of enough large size lesion for diagnosis in Pakistan (Shehzad et al. 2019; Curley et al. 2015). Furthermore, the patients didn’t express any type of special signs and symptoms and their daily activities performance are either normal or mild difficult in general. Common symptoms includes fever, loss of weight, general weakness, abdominal swelling, yellowing of the sclera and skin and right hypochondrium pain as observed in general liver diseases (Poon et al. 2001). Barcelona Clinic Liver Cancer (BCLC) which describe the patient’s performance status, Child Pugh (liver functional status) and stage of cancer including okuda staging (Stage A, B and C), portal invasion, size and number of lesion play an important role in grading of HCC (Pons et al. 2005; Bray et al. 2018). A recent report from Pakistan reported a high percentage of individual with BCLC-B stage (Shehzad et al. 2019) which supported our results of the current study that most of the patients were diagnosed with BCLC-B stage; an intermediate, mostly asymptomatic, with good performance status and multinodular HCC (Butt et al. 2012). Similarly, BCLC-C patients were the second most widely found patients in this study as reported somewhere else (Shehzad et al. 2019) which include symptomatic patients with advanced disease containing extrahepatic spread and vascular invasion (Raza and Sood 2014). According to a study, 70% of the HCC patients are reported in advanced stages (BCLC-B, C, D) in Pakistan (Shehzad et al. 2019) where curative treatments could not be done. Most of the current studied HCC patients have AFP level < 400 as already reported by somewhere else (Shehzad et al. 2019) and therefore, the updated guidelines for the surveillance of HCC recommend ultrasound every 6 months, rather than combination of ultrasonography and AFP levels (Colombo and Sirlin 2019).
The current study observed Torquetino Virus (TTV) in 42.2% of HCV-associated and 31.5% of HBV associated HCC patients. Similarly, the presence of TTV among HCC patients (Pineau et al. 2000; Tagger et al. 1999), HBV and HCV associated HCC patients (Yamamoto et al. 1998), HBV carrier (Devalle and Niel 2004), among non-HCC and HCC patients (Devalle and Niel 2004, 2005; Shibayama et al. 2001), renal transplant patients (Takemoto et al. 2015), lung cancer patients (Bando et al. 2008; Stefani et al. 2021), transplant patients (Focosi et al. 2014; Frye et al. 2019; Gilles et al. 2017; Görzer et al. 2015), HCV patients (Maggi et al. 2003; Mousavi-Nasab et al. 2013; Koohi et al. 2012) has been reported. Furthermore, high load of TTV was non-significantly associated with HCV-associated HCC patients (Tokita et al. 2002) and decompensated cirrhosis or HCC associated HCV patients (Zein et al. 1999). Additionally, TTV-associated HCV-linked HCC patients had higher levels of irregular hepatocytes regeneration (a major risk factor in HCC development) as compare to non-infected TTV patients (Moriyama et al. 2001), aiding the hypothesis about the role of TTV in hepatocarcinogenesis. However, the significant association of HCC with high burden of TTV has been explained through an alternative way by some other studies (Tokita et al. 2002).
The current study also found the prevalence of SEN Viruses in the plasma of HCC patients which is in accordance to the previous report of high prevalence of SEN-V in hepatic viral infected patients from China (Moriyama et al. 2003; Umemura et al. 2001; Shibata et al. 2001). These studies find non-significant adverse clinical characteristics among SEN-V DNA-negative and –positive patients which suggests that co-infection of chronic SEN-V with HCV or HBV associated chronic liver infections didn’t modify the serological features of the patients (Moriyama et al. 2003). The SEN-V has been transmitted through intravenous route, fecal-oral route (Tanaka et al. 2001; Umemura et al. 2001) and vertical infection and henceforth, vertical route and fecal-oral route are thought to be vital for infection with SEN-V transmission as both SEN-V and TTV belongs to the same virus family (Tanaka et al. 2001; Okamoto et al. 1998; Umemura et al. 2001).
The finding of the current study regarding the presence of Herpes viruses showed the prevalence of HSV among HCC patients where several other studies reported its presence among blood donors (Juhl et al. 2010), HIV patients (Zuckerman et al. 2007; Sudenga et al. 2012), central nervous system (Duarte et al. 2019) and general population (Xu et al. 2006) has been already reported in earlier literature. Surprisingly we didn’t detect the presence of EBV DNA among HCC patients as reported in the earlier studies (Gomaa et al. 2022; Li et al. 2004; Chu et al. 2001a; Chen et al. 2019; Akhter et al. 2003; Junying et al. 2003; Zur Hausen et al. 2003; Herrmann and Niedobitek 2003). The current study didn’t find EBV among the plasma of HCC whereas several previous reports published controversial results about the association of EBV with the initiation and development of malignancies like esophageal cancer (Kijima et al. 2001; Wang et al. 1999), breast cancer (Bonnet et al. 1999; Touitou et al. 2001; Chu et al. 2001b; Preciado 2003), colorectal cancer and gastric cancer whereas a strong association has been observed in various studies from Taiwan and Japan as compare to western countries. It has been found in a study that development of HCC has been promoted by infection of EBV, playing a significant role in malignancy of HCC, probably by directly influencing tumorigenic potential or promoting the proliferation of carcinoma cells, exacerbating inflammatory processes in liver tissue, or promoting HCV replication (Li et al. 2004). Henceforth, this study assumes that the association of HCC with EBV may differ with racial and regional differences which need further research.
The current study reported a low prevalence of HEV among the plasma of HCC patients as reported somewhere else (Lin et al. 2020; Atsama et al. 2017; Bai et al. 2018). Additionally, other studies reported that HEV infection accelerate the development of liver cirrhosis (Gérolami et al. 2008; Kamar et al. 2017) which further leads to hepatocellular carcinoma. Furthermore, in case of HBV/HCV or alcohol associated HCC the HEV may work as a co-factor where it can be treated in three months in 80% of the patients by prescribing ribavirin or by decreasing the dosage of immunosuppressive medicine and in case of relapsing or non-responsive virological response, an additional 6-month therapy has been suggested (Kamar et al. 2017). Conclusively, the prevalence of HEV has been neglected in most of the cases of chronic and acute hepatitis as well as HCC (Colson and Raoult 2017). Human cytomegalovirus (HCMV) is a beta herpesvirus which is highly prevalent and transmissible (Britt 2008; Staras et al. 2006) persistently observed in diverse number of body tissues persisting their through hypothesized pathway including latent infection with periodic subclinical reactivation or productive chronic infection and hence never cleared from the body (Coaquette et al. 2004; Britt 2008). The current study finds the prevalence of HCMV among HCC patients as reported somewhere else (Lepiller et al. 2011). Recent research reported the association of HCMV with the inflammatory components of various chronic diseases including cancer (Michaelis et al. 2009), functional impairment (Wang et al. 2010), cognitive decline including vascular dementia (Aiello et al. 2006), cardiovascular disease (Smieja et al. 2003) and hepatitis (Ten Napel et al. 1984). The presence of CMV among HCC patients in the current study might be justified as HCMV could be due to the circulating monocytes reached to liver due to its inflammation or infection of liver vessels (Khan et al. 2009; Guetta et al. 1997). Advancement in CMV infection could play a role in organ failure and mortality (Rafailidis et al. 2008; Razonable and Emery 2004). Concurrently, a recent reports published the potential oncolytic activity, accelerates apoptosis and infiltration and stimulation of immune cell in the microenvironment of tumor (Herbein and Nehme 2020). The anti-cancer abilities of CMV has been proven in various animal and human models of cancers recently (Herbein and Nehme 2020; Klyushnenkova et al. 2012; Kumar et al. 2016; Qiu et al. 2015). The current study established that HCC patients are reservoir of various pathogenic and non-pathogenic viruses which might be involved in pathogenesis, progression and severity of the disease.
Data availability
All pertinent study data that has been gathered is presented and included in this publication; however, the correspondence author can be contacted with any additional questions.
References
Abbasi A, Butt N, Bhutto AR, Gulzar K, Munir S (2010) Hepatocellular carcinoma: a clinicopathological study. J Coll Physicians Surg Pak 20(8):510–513
Aiello AE, Haan MN, Blythe L, Moore K, Gonzalez JM, Jagust W (2006) The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc 54(7):1046–1054
Akhter S, Liu H, Prabhu R, DeLucca C, Bastian F, Garry RF, Schwartz M, Thung SN, Dash S (2003) Epstein–Barr virus and human hepatocellular carcinoma. Cancer Lett 192(1):49–57
Aljumah AA, Kuriry H, AlZunaitan M, Al Ghobain M, Al Muaikeel M, Al Olayan A, Azzumeea F, Almutairi B, AlAlwan A, AlGhamdi H (2016) Clinical presentation, risk factors, and treatment modalities of hepatocellular carcinoma: a single tertiary care center experience. Gastroenterology Research and Practice 2016
Atsama MA, Atangana PJA, Noah DN, Moundipa PF, Pineau P, Njouom R (2017) Hepatitis E virus infection as a promoting factor for hepatocellular carcinoma in Cameroon: preliminary observations. Int J Infect Dis 64:4–8
Bai M-J, Zhou N, Dong W, Li G-X, Cong W, Zhu X-Q (2018) Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China. Int J Infect Dis 71:42–47
Bando M, Takahashi M, Ohno S, Hosono T, Hironaka M, Okamoto H, Sugiyama Y (2008) Torque Teno virus DNA titre elevated in idiopathic pulmonary fibrosis with primary lung cancer. Respirology 13(2):263–269
Berg G, Rybakova D, Fischer D, Cernava T, Vergès M-CC, Charles T, Chen X, Cocolin L, Eversole K, Corral GH (2020) Microbiome definition re-visited: old concepts and new challenges. Microbiome 8(1):1–22
Bonnet M, Guinebretiere J-M, Kremmer E, Grunewald V, Benhamou E, Contesso G, Joab I (1999) Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 91(16):1376–1381
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 68(6):394–424
Britt W (2008) Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Hum Cytomegalovirus :417–470
Butt AS, Abbas Z, Jafri W (2012) Hepatocellular carcinoma in pakistan: where do we stand? Hepatitis monthly 12 (10 HCC)
Chen Z-x, Peng X-t, Tan L, Zhai G-q, Chen G, Gan T-q, Li J-j (2019) EBV as a potential risk factor for hepatobiliary system cancer: a meta-analysis with 918 cases. Pathology-Research Pract 215(2):278–285
Child C, Turcotte J (1964) Surgery and portal hypertension. The liver and portal hypertension. Saunders, Philadelphia, pp 50–64
Choi S, Sohn K-H, Jung J-W, Kang M-G, Yang M-S, Kim S, Choi J-H, Cho S-H, Kang H-R, Yi H (2021) Lung virome: new potential biomarkers for asthma severity and exacerbation. J Allergy Clin Immunol 148(4):1007–1015 e1009
Chow C-ET, Suttle CA (2015) Biogeography of viruses in the sea. Annual Rev Virol 2:41–66
Chu PG, Chang KL, Chen Y-Y, Chen W-G, Weiss LM (2001a) No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am J Pathol 159(2):571–578
Chu PG, Chen Y-Y, Chen W-g, Weiss LM (2001b) No direct role for Epstein-Barr virus in American hepatocellular carcinoma. Am J Pathol 159(4):1287–1292
Coaquette A, Bourgeois A, Dirand C, Varin A, Chen W, Herbein G (2004) Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 39(2):155–161
Colombo M, Sirlin CB (2019) Surveillance for hepatocellular carcinoma in adults
Colson P, Raoult D (2017) Autochthonous hepatitis E: a common and fatal but neglected emerging disease in France. Clin Microbiol Infect 23(12):898–899
Curley SA, Barnett C, Abdalla E (2015) Staging and prognostic factors in hepatocellular carcinoma. UpToDate 10
de Martel C, Maucort-Boulch D, Plummer M, Franceschi S (2015) World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology 62(4):1190–1200
Delwart E (2012) Animal virus discovery: improving animal health, understanding zoonoses, and opportunities for vaccine development. Curr Opin Virol 2(3):344–352
Devalle S, Niel C (2004) Distribution of TT virus genomic groups 1–5 in Brazilian blood donors, HBV carriers, and HIV-1‐infected patients. J Med Virol 72(1):166–173
Devalle S, Niel C (2005) A multiplex PCR assay able to simultaneously detect Torque Teno virus isolates from phylogenetic groups 1 to 5. Braz J Med Biol Res 38:853–860
Dodi G, Attanasi M, Di Filippo P, Di Pillo S, Chiarelli F (2021) Virome in the lungs: the role of anelloviruses in childhood respiratory diseases. Microorganisms 9(7):1357
Duarte LF, Farías MA, Álvarez DM, Bueno SM, Riedel CA, González PA (2019) Herpes simplex virus type 1 infection of the central nervous system: insights into proposed interrelationships with neurodegenerative disorders. Front Cell Neurosci 13:46
Edridge AW, Deijs M, Namazzi R, Cristella C, Jebbink MF, Maurer I, Kootstra NA, Buluma LR, van Woensel JB, de Jong MD (2019) Novel orthobunyavirus identified in the cerebrospinal fluid of a Ugandan child with severe encephalopathy. Clin Infect Dis 68(1):139–142
El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142(6):1264–1273 e1261
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386
Focosi D, Macera L, Pistello M, Maggi F (2014) Torque Teno virus viremia correlates with intensity of maintenance immunosuppression in adult orthotopic liver transplant. J Infect Dis 210(4):667–668
French RK, Holmes EC (2020) An ecosystems perspective on virus evolution and emergence. Trends Microbiol 28(3):165–175
Frye BC, Bierbaum S, Falcone V, Köhler TC, Gasplmayr M, Hettich I, Dürk T, Idzko M, Zissel G, Hengel H (2019) Kinetics of torque teno virus-DNA plasma load predict rejection in lung transplant recipients. Transplantation 103(4):815–822
Gérolami R, Moal V, Colson P (2008) Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 358(8):859–860
Gilles R, Herling M, Holtick U, Heger E, Awerkiew S, Fish I, Höller K, Sierra S, Knops E, Kaiser R (2017) Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation. Med Microbiol Immunol 206:355–362
Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD (2008) Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterology: WJG 14(27):4300
Gomaa HH, Mohammed EMAEA, Attia FM, Saleh RM (2022) Detection of Epstein Barr Virus in Hepatocellular Carcinoma patients in Suez Canal Region: a case-control study. Egypt J Hosp Med 89(2):7769–7774
Görzer I, Jaksch P, Kundi M, Seitz T, Klepetko W, Puchhammer-Stöckl E (2015) Pre-transplant plasma Torque Teno virus load and increase dynamics after lung transplantation. PLoS ONE 10(4):e0122975
Grard G, Fair JN, Lee D, Slikas E, Steffen I, Muyembe J-J, Sittler T, Veeraraghavan N, Ruby JG, Wang C (2012) A novel rhabdovirus associated with acute hemorrhagic fever in central Africa
Guetta E, Guetta V, Shibutani T, Epstein SE (1997) Monocytes harboring cytomegalovirus: interactions with endothelial cells, smooth muscle cells, and oxidized low-density lipoprotein: possible mechanisms for activating virus delivered by monocytes to sites of vascular injury. Circul Res 81(1):8–16
Hafeez M, Nadeem M, Ahmed M (2020) Hepatocellular Carcinoma (HCC), where do we stand? Current situation. Pakistan J Med Sci 36(3):344
Handley SA (2016) The virome: a missing component of biological interaction networks in health and disease. Genome Med 8:1–3
Hannigan GD, Duhaime MB, Ruffin IVMT, Koumpouras CC, Schloss PD (2018) Diagnostic potential and interactive dynamics of the colorectal cancer virome. MBio 9(6). https://doi.org/10.1128/mbio02248 – 02218
Herbein G, Nehme Z (2020) Tumor control by cytomegalovirus: a door open for oncolytic virotherapy? Mol Therapy-Oncolytics 17:1–8
Herrmann K, Niedobitek G (2003) Epstein–Barr virus-associated carcinomas: facts and fiction. J Pathology: J Pathological Soc Great Br Irel 199(2):140–145
Hsu CL, Duan Y, Fouts DE, Schnabl B (2021) Intestinal virome and therapeutic potential of bacteriophages in liver disease. J Hepatol 75(6):1465–1475
Juhl D, Mosel C, Nawroth F, Funke AM, Dadgar S, Hagenström H, Kirchner H, Hennig H (2010) Detection of herpes simplex virus DNA in plasma of patients with primary but not with recurrent infection: implications for transfusion medicine? Transfus Med 20(1):38–47
Junying J, Herrmann K, Davies G, Lissauer D, Bell A, Timms J, Reynolds GM, Hubscher SG, Young LS, Niedobitek G (2003) Absence of Epstein–Barr virus DNA in the tumor cells of European hepatocellular carcinoma. Virology 306(2):236–243
Kamar N, Izopet J, Pavio N, Aggarwal R, Labrique A, Wedemeyer H, Dalton HR (2017) Hepatitis E virus infection. Nat Reviews Disease Primers 3(1):1–16
Kamath PS, Kim WR (2007) The model for end-stage liver disease (MELD). Hepatology 45(3):797–805
Kaya E, Mazzolini GD, Yilmaz Y, Canbay A Prevention of hepatocellular carcinoma and monitoring of high-risk patients. In: Hepatology Forum, 2022. vol 1. Turkish Association for the Study of the Liver, p 33
Khan KA, Coaquette A, Davrinche C, Herbein G (2009) Bcl-3-regulated transcription from major immediate-early promoter of human cytomegalovirus in monocyte-derived macrophages. J Immunol 182(12):7784–7794
Kijima Y, Hokita S, Takao S, Baba M, Natsugoe S, Yoshinaka H, Aridome K, Otsuji T, Itoh T, Tokunaga M (2001) Epstein-Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms. J Med Virol 64(4):513–518
Klyushnenkova EN, Kouiavskaia DV, Parkins CJ, Caposio P, Botto S, Alexander RB, Jarvis MA (2012) A cytomegalovirus-based vaccine expressing a single tumor-specific CD8 + T cell epitope delays tumor growth in a murine model of prostate cancer. Journal of Immunotherapy (Hagerstown, Md: 1997) 35 (5):390
Koohi AK, Ravanshad M, Rasouli M, Falahi S, Baghban A (2012) Phylogenetic analysis of torque teno virus in hepatitis C virus infected patients in shiraz. Hepat Monthly 12(7):437
Koonin EV, Dolja VV, Krupovic M (2021) The healthy human virome: from virus–host symbiosis to disease. Curr Opin Virol 47:86–94
Kumar A, Coquard L, Pasquereau S, Russo L, Valmary-Degano S, Borg C, Pothier P, Herbein G (2016) Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinoma. Molecular Therapy-Oncolytics 3
Lang S, Demir M, Martin A, Jiang L, Zhang X, Duan Y, Gao B, Wisplinghoff H, Kasper P, Roderburg C (2020) Intestinal virome signature associated with severity of nonalcoholic fatty liver disease. Gastroenterology 159(5):1839–1852
Legoff J, Resche-Rigon M, Bouquet J, Robin M, Naccache SN, Mercier-Delarue S, Federman S, Samayoa E, Rousseau C, Piron P (2017) The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host disease. Nat Med 23(9):1080–1085
Lepiller Q, Tripathy MK, Di Martino V, Kantelip B, Herbein G (2011) Increased HCMV seroprevalence in patients with hepatocellular carcinoma. Virol J 8(1):1–10
Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R (2008) Evolution of mammals and their gut microbes. Science 320(5883):1647–1651
Li W, Wu B-A, Zeng Y-M, Chen G-C, Li X-X, Chen J-T, Guo Y-W, Li M-H, Zeng Y (2004) Epstein-Barr virus in hepatocellular carcinogenesis. World J Gastroenterology: WJG 10(23):3409
Li S-K, Leung RK, Guo H-X, Wei J-F, Wang J-H, Kwong K-T, Lee S-S, Zhang C, Tsui S-W (2012) Detection and identification of plasma bacterial and viral elements in HIV/AIDS patients in comparison to healthy adults. Clin Microbiol Infect 18(11):1126–1133
Li L, Deng X, Linsuwanon P, Bangsberg D, Bwana MB, Hunt P, Martin JN, Deeks SG, Delwart E (2013) AIDS alters the commensal plasma virome. J Virol 87(19):10912–10915
Li Y, Fu X, Ma J, Zhang J, Hu Y, Dong W, Wan Z, Li Q, Kuang Y-Q, Lan K (2019) Altered respiratory virome and serum cytokine profile associated with recurrent respiratory tract infections in children. Nat Commun 10(1):2288
Liang G, Bushman FD (2021) The human virome: assembly, composition and host interactions. Nat Rev Microbiol 19(8):514–527
Lin X-N, Lin Q-X, Li S-M, Xie K-P, Hou J, Chen R (2020) Hepatitis E virus re-infection accelerates hepatocellular carcinoma development and relapse in a patient with liver cirrhosis: a case report and review of literature. World J Hepatol 12(12):1358
Liu K, Li Y, Xu R, Zhang Y, Zheng C, Wan Z, Li H, Yang Z, Jin X, Hao P (2021) HIV-1 infection alters the viral composition of plasma in men who have sex with men. Msphere 6(3). https://doi.org/10.1128/msphere00081 – 00021
Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100(10):698–711
Llovet J, Kelley R, Villanueva A, Singal A, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn R (2021) Hepatocellular carcinoma Nat Rev Dis Primers. 7: 6. Article
Lloyd-Price J, Abu-Ali G, Huttenhower C (2016) The healthy human microbiome. Genome Med 8(1):1–11
Ma J, Lv X-L, Zhang X, Han S-Z, Wang Z-D, Li L, Sun H-T, Ma L-X, Cheng Z-L, Shao J-W (2021) Identification of a new orthonairovirus associated with human febrile illness in China. Nat Med 27(3):434–439
Maggi F, Fornai C, Tempestini E, Andreoli E, Lanini L, Vatteroni M, Pistello M, Marchi S, Antonelli G, Bendinelli M (2003) Relationships between TT virus infection and hepatitis C virus response to interferon therapy in doubly infected patients. J Biol Regul Homeost Agents 17(2):176–182
Michaelis M, Doerr HW, Cinatl J Jr (2009) The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 11(1):1–9
Minot S, Bryson A, Chehoud C, Wu GD, Lewis JD, Bushman FD (2013) Rapid evolution of the human gut virome. Proceedings of the National Academy of Sciences 110 (30):12450–12455
Mittal S, Kanwal F, Ying J, Chung R, Sada YH, Temple S, Davila JA, El-Serag HB (2016) Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: a United States cohort. J Hepatol 65(6):1148–1154
Moriyama M, Matsumura H, Shimizu T, Shioda A, Kaneko M, Miyazawa K, Miyata H, Tanaka N, Uchida T, Arakawa Y (2001) Histopathologic impact of TT virus infection on the liver of type C chronic hepatitis and liver cirrhosis in Japan. J Med Virol 64(1):74–81
Moriyama M, Mikuni M, Longren W, Zi-Yi Z, Xueqing W, Oshiro S, Matsumura H, Aoki H, Ichijima S, Iwasaki H (2003) Epidemiology of SEN virus infection among patients with hepatitis B and C in China. Hepatol Res 27(3):174–180
Mousavi-Nasab S, Baharlou R, Ghaderi M, Doosti M, Hashemi S, Samie A, Jahanabadi S, Ahmadi-Vasmehjani A (2013) Molecular epidemiology of torque teno virus (TTV) isolated from in healthy and subjects with chronic hepatitis B and C in Jahrom city of Iran. مجله ویروس شناسی ایران 7(1):44–50
Moustafa A, Xie C, Kirkness E, Biggs W, Wong E, Turpaz Y, Bloom K, Delwart E, Nelson KE, Venter JC (2017) The blood DNA virome in 8,000 humans. PLoS Pathog 13(3):e1006292
Nayfach S, Páez-Espino D, Call L, Low SJ, Sberro H, Ivanova NN, Proal AD, Fischbach MA, Bhatt AS, Hugenholtz P (2021) Metagenomic compendium of 189,680 DNA viruses from the human gut microbiome. Nat Microbiol 6(7):960–970
Norman JM, Handley SA, Baldridge MT, Droit L, Liu CY, Keller BC, Kambal A, Monaco CL, Zhao G, Fleshner P (2015) Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160(3):447–460
Oh J, Byrd AL, Park M, Kong HH, Segre JA (2016) Temporal stability of the human skin microbiome. Cell 165(4):854–866
Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Iizuka H, Miyakawa Y, Mayumi M (1998) Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 10(1):1–16
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–656
Paez-Espino D, Eloe-Fadrosh EA, Pavlopoulos GA, Thomas AD, Huntemann M, Mikhailova N, Rubin E, Ivanova NN, Kyrpides NC (2016) Uncovering Earth’s virome. Nature 536(7617):425–430
Pineau P, Meddeb M, Raselli R, Qin L-X, Terris B, Tang Z-Y, Tiollais P, Mazzaferro V, Dejean A (2000) Effect of TT virus infection on hepatocellular carcinoma development: results of a Euro-Asian survey. J Infect Dis 181(3):1138–1142
Pons F, Varela M, Llovet JM (2005) Staging systems in hepatocellular carcinoma. Hpb 7(1):35–41
Poon RT-P, Fan S-T, Lo C-M, Ng IO-L, Liu C-L, Lam C-M, Wong J (2001) Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234(1):63
Preciado MV (2003) Lack of evidence for an association of Epstein–Barr virus infection with breast carcinoma–another point of view. Breast Cancer Res 5:1–1
Pugh R, Murray-Lyon I, Dawson J, Pietroni M, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8):646–649
Qiu Z, Huang H, Grenier JM, Perez OA, Smilowitz HM, Adler B, Khanna KM (2015) Cytomegalovirus-based vaccine expressing a modified tumor antigen induces potent tumor-specific CD8 + T-cell response and protects mice from melanoma. Cancer Immunol Res 3(5):536–546
Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME (2008) Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 5:1–7
Raza A, Sood GK (2014) Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World J Gastroenterology: WJG 20(15):4115
Razonable RR, Emery VC (2004) Management of CMV infection and disease in transplant patients. 27–29 February 2004. Herpes: J IHMF 11(3):77–86
Romeo R, Petruzziello A, Pecheur EI, Facchetti F, Perbellini R, Galmozzi E, Khan NU, Di Capua L, Sabatino R, Botti G (2018) Hepatitis delta virus and hepatocellular carcinoma: an update. Epidemiol Infect 146(13):1612–1618
Shehzad A, Sajjad R, Shabbir K, Qureshi ZA, Saeed F, Qamar A (2019) HEPATOCELLULAR CARCINOMA AT INITIAL PRESENTATION AND ITS SUBSEQUENT THERAPEUTIC OPTIONS OFFERED: A TERTIARY CARE HOSPITAL EXPERIENCE. Pakistan Armed Forces Med J 69(5):1051–1056
Shi M, Lin X-D, Chen X, Tian J-H, Chen L-J, Li K, Wang W, Eden J-S, Shen J-J, Liu L (2018) The evolutionary history of vertebrate RNA viruses. Nature 556(7700):197–202
Shibata M, Wang RY-H, Yoshiba M, Shih JW-K, Alter HJ, Mitamura K (2001) The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan. J Infect Dis 184(4):400–404
Shibayama T, Masuda G, Ajisawa A, Takahashi M, Nishizawa T, Tsuda F, Okamoto H (2001) Inverse relationship between the titre of TT virus DNA and the CD4 cell count in patients infected with HIV. Aids 15(5):563–570. https://doi.org/10.1097/00002030-200103300-00004
Smieja M, Gnarpe J, Lonn E, Gnarpe Hk, Olsson G, Yi Q, Dzavik V, McQueen M, Yusuf S (2003) Multiple infections and subsequent cardiovascular events in the Heart outcomes Prevention evaluation (HOPE) study. Circulation 107(2):251–257
Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ (2006) Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis 43(9):1143–1151
Stefani D, Hegedues B, Collaud S, Zaatar M, Ploenes T, Valdivia D, Elsner C, Bleekmann B, Widera M, Dittmer U (2021) Torque Teno Virus load in lung cancer patients correlates with age but not with tumor stage. PLoS ONE 16(6):e0252304
Sudenga SL, Kempf M-C, McGwin G Jr, Wilson CM, Hook E III, Shrestha S (2012) Incidence, prevalence and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents. Sex Transm Dis 39(4):300
Tagger A, Donato F, Ribero ML, Binelli G, Gelatti U, Portera G, Albertini A, Fasola M, Chiesa R, Nardi G (1999) A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma. Hepatology 30(1):294–299
Takemoto AY, Okubo P, Saito PK, Yamakawa RH, Watanabe MAE, Veríssimo da Silva Junior W, Borelli SD, Bedendo J (2015) Torque Teno virus among dialysis and renal-transplant patients. Brazilian J Microbiol 46:307–311
Tanaka Y, Primi D, Wang RY, Umemura T, Yeo AE, Mizokami M, Alter HJ, Shih JW-K (2001) Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family. J Infect Dis 183(3):359–367
Ten Napel CH, Houthoff H, The T (1984) Cytomegalovirus hepatitis in normal and immune compromised hosts. Liver 4(3):184–194
Tokita H, Murai S, Kamitsukasa H, Yagura M, Harada H, Takahashi M, Okamoto H (2002) High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease. J Med Virol 67(4):501–509
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. Cancer J Clin 65(2):87–108
Touitou R, Bonnet-Duquenoy M, Joab I (2001) Association of Epstein-Barr virus with human mammary carcinoma. Pros cons Disease Markers 17(3):163–165
Umemura T, Yeo AE, Sottini A, Moratto D, Tanaka Y, Wang RY-H, Shih JW-K, Donahue P, Primi D, Alter HJ (2001) SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology 33(5):1303–1311
Umer M, Iqbal M (2016) Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data. World J Gastroenterol 22(4):1684
Wang L-S, Chow K-C, Wu Y-C, Li W-Y, Huang M-H (1999) Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan. Am J Gastroenterol 94(10):2834–2839
Wang GC, Kao WHL, Murakami P, Xue Q-L, Chiou RB, Detrick B, McDyer JF, Semba RD, Casolaro V, Walston JD (2010) Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am J Epidemiol 171(10):1144–1152
Wang J, Li Y, He X, Ma J, Hong W, Hu F, Zhao L, Li Q, Zhang J, Zhang C (2019) Gemykibivirus genome in lower respiratory tract of elderly woman with unexplained acute respiratory distress syndrome. Clin Infect Dis 69(5):861–864
Wilson MR, Sample HA, Zorn KC, Arevalo S, Yu G, Neuhaus J, Federman S, Stryke D, Briggs B, Langelier C (2019) Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N Engl J Med 380(24):2327–2340
Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE (2006) Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296(8):964–973
Yamamoto T, Kajino K, Ogawa M, Gotoh I, Matsuoka S, Suzuki K, Moriyama M, Okubo H, Kudo M, Arakawa Y (1998) Hepatocellular carcinomas infected with the novel TT DNA virus lack viral integration. Biochem Biophys Res Commun 251(1):339–343
Zanella M-C, Cordey S, Kaiser L (2020) Beyond cytomegalovirus and Epstein-Barr virus: a review of viruses composing the blood virome of solid organ transplant and hematopoietic stem cell transplant recipients. Clin Microbiol Rev 33(4). https://doi.org/10.1128/cmr00027 – 00020
Zanella M-C, Cordey S, Laubscher F, Docquier M, Vieille G, Van Delden C, Braunersreuther V, TA MK, Lobrinus J, Masouridi-Levrat S (2021) Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host disease. Microbiome 9(1):1–12
Zein NN, Arslan M, Li H, Charlton MR, Gross JB Jr, Poterucha JJ, Therneau TM, Kolbert CP, Persing DH (1999) Clinical significance of TT virus infection in patients with chronic hepatitis C. Am J Gastroenterol 94(10):3020–3027
Zhang Y-Z, Shi M, Holmes EC (2018) Using metagenomics to characterize an expanding virosphere. Cell 172(6):1168–1172
Zhao G, Vatanen T, Droit L, Park A, Kostic AD, Poon TW, Vlamakis H, Siljander H, Härkönen T, Hämäläinen A-M (2017) Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children. Proc Natl Acad Sci 114(30):E6166–E6175
Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270–273
Zuckerman RA, Lucchetti A, Whittington WL, Sánchez J, Coombs RW, Zuñiga R, Magaret AS, Wald A, Corey L, Celum C (2007) Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis 196(10):1500–1508
Zur Hausen A, van Beek J, Bloemena E, Ten Kate FJ, Meijer CJ, van den Brule AJ (2003) No role for Epstein–Barr virus in Dutch hepatocellular carcinoma: a study at the DNA, RNA and protein levels. J Gen Virol 84(7):1863–1869
Acknowledgements
The authors acknowledge Researchers Supporting Project number (RSP2024R457), King Saud University, Riyadh, Saudi Arabia for financial support.
Funding
This work is financially supported by the Researchers Supporting Project (RSP2024R457). King Saud University, Riyadh, Saudi Arabia.
Author information
Authors and Affiliations
Contributions
I.A. and J.K. planned study; Data was collected by N.U., Z.U.H., J.K., A.S. and N.B.; Lab work and Data Analysis were done by N.U., J.K., A.S., T.A.S, N.B; Critical review, evaluation and final drafting of the manuscript was done by I.A., M.B, Y.A.B.J, G.F.W. All authors have read and agreed to the published version of the manuscript.
Corresponding authors
Ethics declarations
Institutional review board statement
Ethical Review Board of COMSATS University, Islamabad, Pakistan, approved this study before starting of this study.
Informed consent statement
Every participant in the study gave their informed consent. The patient(s) has(have) given their written informed consent for this paper to be published.
Conflict of interest
No conflicts of interest are disclosed by the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ullah Khan, N., Sadiq, A., Khan, J. et al. Molecular characterization of plasma virome of hepatocellular carcinoma (HCC) patients. AMB Expr 14, 46 (2024). https://doi.org/10.1186/s13568-024-01696-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13568-024-01696-2